Literature DB >> 21490328

Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle.

Ricardo Villa-Bellosta1, Xiaonan Wang, José Luis Millán, George R Dubyak, W Charles O'Neill.   

Abstract

Extracellular inorganic pyrophosphate (ePP(i)) is an important endogenous inhibitor of vascular calcification, but it is not known whether systemic or local vascular PP(i) metabolism controls calcification. To determine the role of ePP(i) in vascular smooth muscle, we identified the pathways responsible for ePP(i) production and hydrolysis in rat and mouse aortas and manipulated them to demonstrate their role in the calcification of isolated aortas in culture. Rat and mouse aortas contained mRNA for ectonucleotide pyrophosphatase/phosphodiesterases (NPP1-3), the putative PP(i) transporter ANK, and tissue-nonspecific alkaline phosphatase (TNAP). Synthesis of PP(i) from ATP in aortas was blocked by β,γ-methylene-ATP, an inhibitor of NPPs. Aortas from mice lacking NPP1 (Enpp1(-/-)) did not synthesize PP(i) from ATP and exhibited increased calcification in culture. Although ANK-mediated transport of PP(i) could not be demonstrated in aortas, aortas from mutant (ank/ank) mice calcified more in culture than did aortas from normal (ANK/ANK) mice. Hydrolysis of PP(i) was reduced 25% by β,γ-methylene-ATP and 50% by inhibition of TNAP. Hydrolysis of PP(i) was increased in cells overexpressing TNAP or NPP3 but not NPP1 and was not reduced in Enpp1(-/-) aortas. Overexpression of TNAP increased calcification of cultured aortas. The results show that smooth muscle NPP1 and TNAP control vascular calcification through effects on synthesis and hydrolysis of ePP(i), indicating an important inhibitory role of locally produced PP(i). Smooth muscle ANK also affects calcification, but this may not be mediated through transport of PP(i). NPP3 is identified as an additional pyrophosphatase that could influence vascular calcification.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490328      PMCID: PMC3129914          DOI: 10.1152/ajpheart.01020.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  22 in total

1.  Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone.

Authors:  Monzur Murshed; Dympna Harmey; José Luis Millán; Marc D McKee; Gerard Karsenty
Journal:  Genes Dev       Date:  2005-04-15       Impact factor: 11.361

2.  PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification.

Authors:  F Rutsch; S Vaingankar; K Johnson; I Goldfine; B Maddux; P Schauerte; H Kalhoff; K Sano; W A Boisvert; A Superti-Furga; R Terkeltaub
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Treatment with pyrophosphate inhibits uremic vascular calcification.

Authors:  W Charles O'Neill; Koba A Lomashvili; Hartmut H Malluche; Marie-Claude Faugere; Bruce L Riser
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

4.  Can biological calcification occur in the presence of pyrophosphate?

Authors:  J L Meyer
Journal:  Arch Biochem Biophys       Date:  1984-05-15       Impact factor: 4.013

5.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

6.  Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.

Authors:  K A Lomashvili; P Garg; S Narisawa; J L Millan; W C O'Neill
Journal:  Kidney Int       Date:  2008-02-20       Impact factor: 10.612

7.  Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).

Authors:  Russell Dahl; Eduard A Sergienko; Ying Su; Yalda S Mostofi; Li Yang; Ana Maria Simao; Sonoko Narisawa; Brock Brown; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H Smith; W Charles O'Neill; José Luis Millán; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

Review 8.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

9.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.

Authors:  Simon C Robson; Jean Sévigny; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

10.  Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics.

Authors:  Ana Maria S Simão; Manisha C Yadav; Sonoko Narisawa; Mayte Bolean; Joao Martins Pizauro; Marc F Hoylaerts; Pietro Ciancaglini; José Luis Millán
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

View more
  45 in total

Review 1.  Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Authors:  Mathias Haarhaus; Vincent Brandenburg; Kamyar Kalantar-Zadeh; Peter Stenvinkel; Per Magnusson
Journal:  Nat Rev Nephrol       Date:  2017-05-15       Impact factor: 28.314

Review 2.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 3.  Insights into autotaxin: how to produce and present a lipid mediator.

Authors:  Wouter H Moolenaar; Anastassis Perrakis
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-14       Impact factor: 94.444

Review 4.  Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel.

Authors:  Frank Rutsch; Yvonne Nitschke; Robert Terkeltaub
Journal:  Circ Res       Date:  2011-08-19       Impact factor: 17.367

Review 5.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

Review 6.  Regulatory circuits controlling vascular cell calcification.

Authors:  Tamer Sallam; Henry Cheng; Linda L Demer; Yin Tintut
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

Review 7.  Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.

Authors:  Oscar Leonard; Jonas Spaak; David Goldsmith
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

8.  Inhibition of arterial medial calcification and bone mineralization by extracellular nucleotides: The same functional effect mediated by different cellular mechanisms.

Authors:  Jessal J Patel; Dongxing Zhu; Britt Opdebeeck; Patrick D'Haese; José L Millán; Lucie E Bourne; Caroline P D Wheeler-Jones; Timothy R Arnett; Vicky E MacRae; Isabel R Orriss
Journal:  J Cell Physiol       Date:  2017-10-04       Impact factor: 6.384

Review 9.  Zooming in on the genesis of atherosclerotic plaque microcalcifications.

Authors:  Jessica L Ruiz; Sheldon Weinbaum; Elena Aikawa; Joshua D Hutcheson
Journal:  J Physiol       Date:  2016-05-01       Impact factor: 5.182

10.  Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification.

Authors:  Tina Kiffer-Moreira; Manisha C Yadav; Dongxing Zhu; Sonoko Narisawa; Campbell Sheen; Boguslaw Stec; Nicholas D Cosford; Russell Dahl; Colin Farquharson; Marc F Hoylaerts; Vicky E Macrae; José Luis Millán
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.